Who are Ornidazole and Sodium Chloride Injection's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Metronidazole 400 (7 days), Metronidazole (BQ10), Metronidazole 400 (14 days), Metronidazole (ST14), Metronidazole 250 (14 days), Metronidazole (Metrogel).

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/ornidazole-and-sodium-chloride-injection.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-16 · How we verify

Ornidazole and Sodium Chloride Injection — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Ornidazole and Sodium Chloride Injection (Ornidazole and Sodium Chloride Injection) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Nitroimidazole antibiotic. Area: Infectious Disease.

marketed Nitroimidazole antibiotic Bacterial/parasitic DNA Infectious Disease Small molecule Live · refreshed every 30 min

Target snapshot

Ornidazole and Sodium Chloride Injection (Ornidazole and Sodium Chloride Injection) — Yangtze River Pharmaceutical Group Jiangsu Zilong Pharmaceutical Co. Ltd. Ornidazole is a nitroimidazole antibiotic that disrupts bacterial and parasitic DNA by generating reactive oxygen species after reduction of its nitro group.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target
Ornidazole and Sodium Chloride Injection TARGET	Ornidazole and Sodium Chloride Injection	Yangtze River Pharmaceutical Group Jiangsu Zilong Pharmaceutical Co. Ltd	marketed	Nitroimidazole antibiotic	Bacterial/parasitic DNA
Metronidazole 400 (7 days)	Metronidazole 400 (7 days)	University of Guarulhos	marketed	Nitroimidazole antibiotic	Bacterial/parasitic DNA
Metronidazole (BQ10)	Metronidazole (BQ10)	National Taiwan University Hospital	marketed	Nitroimidazole antibiotic	Bacterial/parasitic DNA
Metronidazole 400 (14 days)	Metronidazole 400 (14 days)	University of Guarulhos	marketed	Nitroimidazole antibiotic	Bacterial/parasitic DNA
Metronidazole (ST14)	Metronidazole (ST14)	National Taiwan University Hospital	marketed	Nitroimidazole antibiotic	Bacterial/parasitic DNA
Metronidazole 250 (14 days)	Metronidazole 250 (14 days)	University of Guarulhos	marketed	Nitroimidazole antimicrobial	Bacterial/parasitic DNA
Metronidazole (Metrogel)	Metronidazole (Metrogel)	LEO Pharma	marketed	Nitroimidazole antibiotic	Bacterial/parasitic DNA

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Nitroimidazole antibiotic class)

National Taiwan University Hospital · 2 drugs in this class
Yangtze River Pharmaceutical Group Jiangsu Zilong Pharmaceutical Co. Ltd · 2 drugs in this class
University of Guarulhos · 2 drugs in this class
Johns Hopkins Bloomberg School of Public Health · 1 drug in this class
LEO Pharma · 1 drug in this class
Sherief Abd-Elsalam · 1 drug in this class
University of Alabama at Birmingham · 1 drug in this class
University of Sao Paulo · 1 drug in this class
Appili Therapeutics Inc. · 1 drug in this class
bioRASI, LLC · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Ornidazole and Sodium Chloride Injection — Competitive Intelligence Brief. https://druglandscape.com/ci/ornidazole-and-sodium-chloride-injection. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab